Human umbilical cord mesenchymal stromal cells derivatives in treating diabetic foot ulcers: a phase I/II safety and efficacy trial
Hanan Jafar(University of Jordan), Abdalla Awidi(University of Jordan), Hussam Alhawari(University of Jordan), Diana Shahin(University of Jordan), Nour Aboalhaija(Al-Zaytoonah University of Jordan), Mohammad Al Soudi(University of Jordan), Rami Almousa(Isra University), Elham Abusharieh(University of Jordan)
Cited by 7
Related Papers
siRNA: Mechanism of action, challenges, and therapeutic approaches
|European Journal of Pharmacology|2021|428
Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study
|Journal of Orthopaedic Surgery and Research|2017|141
Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy
|CNS Neuroscience & Therapeutics|2017|123